Spear Bio

Spear Bio is meeting a growing market need for ultrasensitive immunoassays in smaller samples.

Our platform, based on technology licensed from Harvard University, can detect single-digit counts of proteins per sample in minuscule sample volumes.

Our goal is to develop high-impact immunoassays that can be easily adopted by academic and clinical researchers and practitioners.